Market Tracker

07/22 3:04am ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

303.73
Data as of Jul 21
 -2.19 / -0.72%
Today’s Change
227.64
Today|||52-Week Range
352.49
+10.35%
Year-to-Date

Today’s Trading

Previous close305.92
Today’s open306.20
Day’s range302.46 - 307.22
Volume562,231
Average volume (3 months)858,266
Market cap$30.9B
Dividend yield--
Data as of 3:59pm ET, 07/21/2014

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)+20.55%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+52.69%
P/E ratio85.3
Price/Sales12.80
Price/Book15.62

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.06+0.11%
CBSTCubist Pharmaceutica...+0.09+0.14%
ALNYAlnylam Pharmaceutic...+0.29+0.54%
IDIXIdenix Pharmaceutica...+0.22+0.91%
Data as of 4:02pm ET, 07/21/2014

Financials

Next reporting dateAugust 5, 2014
EPS forecast (this quarter)$2.27
Annual revenue (last year)$2.1B
Annual profit (last year)$424.4M
Net profit margin20.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts